A pioneer in nicotine reduction, 22nd Century is well-placed as FDA mulls a mandate for minimally addictive cigarettes. Read More
The trade group wants to help the regulatory agency better understand the constituent. Read More
The sales are part of a national pilot for VLN, the first cigarette to receive modified-risk orders.Read More
The FDA asserts its authority over nontobacco-derived nicotine. Read More
Nveed Chaudhary explains how new FDA powers will impact the industry. Read More
The product could help customers meet the deadline for market applications.Read More
The Tobacco Control Act will redefine the term 'tobacco product' to include lab nicotine. Read More
The legislation now heads to the White House for the president’s signature. Read More
The FDA is poised to receive regulatory authority over the controversial compound. Read More
A bill is giving the agency jurisdiction is slated to be passed in the next few days. Read More
Recent Posts
- Stakeholders Debate Tobacco-Related Forestry in Brazil
- Zimbabwe: Auction Prices Hit Record High
- KT&G Appoints Kyung-man Bang as President and CEO
- 22nd Century Reports Quarterly Results
- Knesset Approves Graphic Warnings
- Singapore Vaping up Despite Ban
- Retailers Warned Over Unauthorized Vapes
- Europe OKs Aid to Bulgarian Growers
- Ukraine: Activists Decry PMI’s tax privileges
- Airscream to Invest in Malaysia
- Phelps to Lead CTP Policy and Partnerships
- Estrogen May Drive Nicotine Addiction
- Luxembourg to Tax Vapes and Pouches
- Tobacco Production Rising in Mozambique
- Harpantidis to Lead PMI External Affairs